Jefferies Group LLC Exelixis, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 70,600 shares of EXEL stock, worth $2.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

70,600

Holding current value

$2.44 Million

% of portfolio

0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$15.68 - $22.27 $526,848 - $748,272	33,600 Added 90.81%	70,600 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $1.48 Million - $2.11 Million	94,588 New	94,588 $1.09 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $1.15 Million - $1.53 Million	-65,914 Closed	0 $0
Q1 2022 Sep 21, 2023	SELL	$17.03 - $22.67 $544,960 - $725,440	-32,000 Reduced 46.38%	37,000 $838,000
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $1.12 Million - $1.49 Million	65,914 New	65,914 $878,000
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $1.09 Million - $1.51 Million	-69,000 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$16.3 - $21.14 $370,645 - $480,702	22,739 Added 49.15%	69,000 $1.46 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $370,645 - $480,702	22,739 Added 49.15%	69,000 $1.46 Million
Q2 2021 Sep 21, 2023	SELL	$17.95 - $25.56 $867,469 - $1.24 Million	-48,327 Reduced 51.09%	46,261 $842,000
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $830,384 - $1.18 Million	46,261 New	46,261 $843,000
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $551,700 - $744,000	-30,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $2.32 Million - $3.02 Million	-112,280 Reduced 78.91%	30,000 $734,000
Q3 2019 Nov 13, 2019	BUY	$17.68 - $22.65 $1.9 Million - $2.44 Million	107,699 Added 311.44%	142,280 $2.52 Million
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $36,951 - $48,312	-1,952 Reduced 5.34%	34,581 $739,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $133,926 - $169,185	-6,833 Reduced 15.76%	36,533 $869,000
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $514,140 - $821,118	37,666 Added 660.81%	43,366 $853,000
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $1.16 Million - $1.63 Million	-72,906 Reduced 92.75%	5,700 $101,000
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $1.46 Million - $1.76 Million	78,606 New	78,606 $1.69 Million
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $529,429 - $762,234	-23,902 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $579,145 - $739,288	23,902	23,902 $727,000

Others Institutions Holding EXEL

# of Institutions

500

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Exelixis, Inc. Transaction History